Quanta

United Kingdom
Alcester, England, United Kingdom, B49 6EU

Company profile

Quanta company profile

Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Business identity

Contact email
[email protected]
Phone number
+44 1789 400043
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$10M+
Founded
2008-01-01, Year

Headquarters

Postal code
B49 6EU
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
6
Total equity funding
$408.9M
Last funding
Series E / $60M / 2024-11-18
Last equity funding
Series E / $60M
Investors
20
Lead investors
6
Founders
2
Articles
73

Founders and investors

Founders

John E. MiladMorgan Intrator

Lead investors

Air Liquideb2ventureGlenview Capital ManagementNovo HoldingsSeroba Life SciencesWellington Partners

Investors

b2ventureBlackRockEldridge IndustriesNovo HoldingsSands Capital Ventures